Last reviewed · How we verify

Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults (RePRIEVE-CM)

NCT03727100 PHASE3 COMPLETED

This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.

Details

Lead sponsorSollis Therapeutics, Inc.
PhasePHASE3
StatusCOMPLETED
Enrolment207
Start dateTue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSat Jul 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States